Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center.

Daly A, Cano DA, Venegas E, Petrossians P, Dios E, Castermans E, Flores-Martínez A, Bours V, Beckers A, Soto A.

Endocr Connect. 2019 Mar 1. pii: EC-19-0027.R3. doi: 10.1530/EC-19-0027. [Epub ahead of print]

2.

The causes and consequences of pituitary gigantism.

Beckers A, Petrossians P, Hanson J, Daly AF.

Nat Rev Endocrinol. 2018 Dec;14(12):705-720. doi: 10.1038/s41574-018-0114-1. Review.

PMID:
30361628
3.

Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database.

Petrossians P, Daly AF, Natchev E, Maione L, Blijdorp K, Sahnoun-Fathallah M, Auriemma R, Diallo AM, Hulting AL, Ferone D, Hana V Jr, Filipponi S, Sievers C, Nogueira C, Fajardo-Montañana C, Carvalho D, Hana V, Stalla GK, Jaffrain-Réa ML, Delemer B, Colao A, Brue T, Neggers SJCMM, Zacharieva S, Chanson P, Beckers A.

Endocr Relat Cancer. 2017 Oct;24(10):505-518. doi: 10.1530/ERC-17-0253. Epub 2017 Jul 21.

4.

Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry.

Maione L, Brue T, Beckers A, Delemer B, Petrossians P, Borson-Chazot F, Chabre O, François P, Bertherat J, Cortet-Rudelli C, Chanson P; French Acromegaly Registry Group.

Eur J Endocrinol. 2017 May;176(5):645-655. doi: 10.1530/EJE-16-1064. Epub 2017 Feb 28.

PMID:
28246150
5.

Erratum to: Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia.

Vroonen L, Lancellotti P, Garcia MT, Dulgheru R, Rubio-Almanza M, Maiga I, Magne J, Petrossians P, Auriemma R, Daly AF, Beckers A.

Endocrine. 2017 Jan;55(1):246. doi: 10.1007/s12020-016-1177-1. No abstract available.

6.

Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia.

Vroonen L, Lancellotti P, Garcia MT, Dulgheru R, Rubio-Almanza M, Maiga I, Magne J, Petrossians P, Auriemma R, Daly AF, Beckers A.

Endocrine. 2017 Jan;55(1):239-245. doi: 10.1007/s12020-016-1120-5. Epub 2016 Oct 5. Erratum in: Endocrine. 2017 Jan;55(1):246.

7.

T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly.

Potorac I, Petrossians P, Daly AF, Alexopoulou O, Borot S, Sahnoun-Fathallah M, Castinetti F, Devuyst F, Jaffrain-Rea ML, Briet C, Luca F, Lapoirie M, Zoicas F, Simoneau I, Diallo AM, Muhammad A, Kelestimur F, Nazzari E, Centeno RG, Webb SM, Nunes ML, Hana V, Pascal-Vigneron V, Ilovayskaya I, Nasybullina F, Achir S, Ferone D, Neggers SJ, Delemer B, Petit JM, Schöfl C, Raverot G, Goichot B, Rodien P, Corvilain B, Brue T, Schillo F, Tshibanda L, Maiter D, Bonneville JF, Beckers A.

Endocr Relat Cancer. 2016 Nov;23(11):871-881. Epub 2016 Sep 20.

8.

High prevalence of autoimmune thyroid diseases in patients with prolactinomas: A cross-sectional retrospective study in a single tertiary referral centre.

Elenkova A, Petrossians P, Zacharieva S, Beckers A.

Ann Endocrinol (Paris). 2016 Feb;77(1):37-42. doi: 10.1016/j.ando.2015.10.008. Epub 2016 Feb 10.

PMID:
26874995
9.

Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.

Rostomyan L, Daly AF, Petrossians P, Nachev E, Lila AR, Lecoq AL, Lecumberri B, Trivellin G, Salvatori R, Moraitis AG, Holdaway I, Kranenburg-van Klaveren DJ, Chiara Zatelli M, Palacios N, Nozieres C, Zacharin M, Ebeling T, Ojaniemi M, Rozhinskaya L, Verrua E, Jaffrain-Rea ML, Filipponi S, Gusakova D, Pronin V, Bertherat J, Belaya Z, Ilovayskaya I, Sahnoun-Fathallah M, Sievers C, Stalla GK, Castermans E, Caberg JH, Sorkina E, Auriemma RS, Mittal S, Kareva M, Lysy PA, Emy P, De Menis E, Choong CS, Mantovani G, Bours V, De Herder W, Brue T, Barlier A, Neggers SJ, Zacharieva S, Chanson P, Shah NS, Stratakis CA, Naves LA, Beckers A.

Endocr Relat Cancer. 2015 Oct;22(5):745-57. doi: 10.1530/ERC-15-0320. Epub 2015 Jul 17.

10.

Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender difference.

Kreutz J, Vroonen L, Cattin F, Petrossians P, Thiry A, Rostomyan L, Tshibanda L, Beckers A, Bonneville JF.

Neuroradiology. 2015 Jul;57(7):679-84. doi: 10.1007/s00234-015-1519-3. Epub 2015 Apr 7.

PMID:
25845810
11.

X-linked acrogigantism syndrome: clinical profile and therapeutic responses.

Beckers A, Lodish MB, Trivellin G, Rostomyan L, Lee M, Faucz FR, Yuan B, Choong CS, Caberg JH, Verrua E, Naves LA, Cheetham TD, Young J, Lysy PA, Petrossians P, Cotterill A, Shah NS, Metzger D, Castermans E, Ambrosio MR, Villa C, Strebkova N, Mazerkina N, Gaillard S, Barra GB, Casulari LA, Neggers SJ, Salvatori R, Jaffrain-Rea ML, Zacharin M, Santamaria BL, Zacharieva S, Lim EM, Mantovani G, Zatelli MC, Collins MT, Bonneville JF, Quezado M, Chittiboina P, Oldfield EH, Bours V, Liu P, W de Herder W, Pellegata N, Lupski JR, Daly AF, Stratakis CA.

Endocr Relat Cancer. 2015 Jun;22(3):353-67. doi: 10.1530/ERC-15-0038. Epub 2015 Feb 24.

12.

Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences.

Potorac I, Petrossians P, Daly AF, Schillo F, Ben Slama C, Nagi S, Sahnoun M, Brue T, Girard N, Chanson P, Nasser G, Caron P, Bonneville F, Raverot G, Lapras V, Cotton F, Delemer B, Higel B, Boulin A, Gaillard S, Luca F, Goichot B, Dietemann JL, Beckers A, Bonneville JF.

Endocr Relat Cancer. 2015 Apr;22(2):169-77. doi: 10.1530/ERC-14-0305. Epub 2015 Jan 2.

PMID:
25556181
13.

McCune-Albright syndrome: a detailed pathological and genetic analysis of disease effects in an adult patient.

Vasilev V, Daly AF, Thiry A, Petrossians P, Fina F, Rostomyan L, Silvy M, Enjalbert A, Barlier A, Beckers A.

J Clin Endocrinol Metab. 2014 Oct;99(10):E2029-38. doi: 10.1210/jc.2014-1291. Epub 2014 Jul 25.

14.

Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients.

Vroonen L, Jaffrain-Rea ML, Petrossians P, Tamagno G, Chanson P, Vilar L, Borson-Chazot F, Naves LA, Brue T, Gatta B, Delemer B, Ciccarelli E, Beck-Peccoz P, Caron P, Daly AF, Beckers A.

Eur J Endocrinol. 2012 Nov;167(5):651-62. doi: 10.1530/EJE-12-0236. Epub 2012 Aug 23. Erratum in: Eur J Endocrinol. 2012 Dec;167(6):887.

15.

The Liege Acromegaly Survey (LAS): a new software tool for the study of acromegaly.

Petrossians P, Tichomirowa MA, Stevenaert A, Martin D, Daly AF, Beckers A.

Ann Endocrinol (Paris). 2012 Jun;73(3):190-201. doi: 10.1016/j.ando.2012.05.001. Epub 2012 Jun 9.

PMID:
22682917
16.

High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.

Tichomirowa MA, Barlier A, Daly AF, Jaffrain-Rea ML, Ronchi C, Yaneva M, Urban JD, Petrossians P, Elenkova A, Tabarin A, Desailloud R, Maiter D, Schürmeyer T, Cozzi R, Theodoropoulou M, Sievers C, Bernabeu I, Naves LA, Chabre O, Montañana CF, Hana V, Halaby G, Delemer B, Aizpún JI, Sonnet E, Longás AF, Hagelstein MT, Caron P, Stalla GK, Bours V, Zacharieva S, Spada A, Brue T, Beckers A.

Eur J Endocrinol. 2011 Oct;165(4):509-15. doi: 10.1530/EJE-11-0304. Epub 2011 Jul 13.

17.

Familial pituitary tumor syndromes.

Vasilev V, Daly AF, Petrossians P, Zacharieva S, Beckers A.

Endocr Pract. 2011 Jul-Aug;17 Suppl 3:41-6. doi: 10.4158/EP11064.RA. Review.

PMID:
21613050
18.

Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry.

Fieffe S, Morange I, Petrossians P, Chanson P, Rohmer V, Cortet C, Borson-Chazot F, Brue T, Delemer B; French Acromegaly Registry.

Eur J Endocrinol. 2011 Jun;164(6):877-84. doi: 10.1530/EJE-10-1050. Epub 2011 Apr 4.

PMID:
21464140
19.

Genetic susceptibility in pituitary adenomas: from pathogenesis to clinical implications.

Jaffrain-Rea ML, Daly AF, Angelini M, Petrossians P, Bours V, Beckers A.

Expert Rev Endocrinol Metab. 2011 Mar;6(2):195-214. doi: 10.1586/eem.10.87.

PMID:
30290451
20.

Medical treatment in Cushing's syndrome: dopamine agonists and cabergoline.

Petrossians P, Thonnard AS, Beckers A.

Neuroendocrinology. 2010;92 Suppl 1:116-9. doi: 10.1159/000317716. Epub 2010 Sep 10. Review.

21.

Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study.

Daly AF, Tichomirowa MA, Petrossians P, Heliövaara E, Jaffrain-Rea ML, Barlier A, Naves LA, Ebeling T, Karhu A, Raappana A, Cazabat L, De Menis E, Montañana CF, Raverot G, Weil RJ, Sane T, Maiter D, Neggers S, Yaneva M, Tabarin A, Verrua E, Eloranta E, Murat A, Vierimaa O, Salmela PI, Emy P, Toledo RA, Sabaté MI, Villa C, Popelier M, Salvatori R, Jennings J, Longás AF, Labarta Aizpún JI, Georgitsi M, Paschke R, Ronchi C, Valimaki M, Saloranta C, De Herder W, Cozzi R, Guitelman M, Magri F, Lagonigro MS, Halaby G, Corman V, Hagelstein MT, Vanbellinghen JF, Barra GB, Gimenez-Roqueplo AP, Cameron FJ, Borson-Chazot F, Holdaway I, Toledo SP, Stalla GK, Spada A, Zacharieva S, Bertherat J, Brue T, Bours V, Chanson P, Aaltonen LA, Beckers A.

J Clin Endocrinol Metab. 2010 Nov;95(11):E373-83. doi: 10.1210/jc.2009-2556. Epub 2010 Aug 4.

22.

Which patients with acromegaly are treated with pegvisomant? An overview of methodology and baseline data in ACROSTUDY.

Brue T, Castinetti F, Lundgren F, Koltowska-Häggström M, Petrossians P; ACROSTUDY investigators.

Eur J Endocrinol. 2009 Nov;161 Suppl 1:S11-7. doi: 10.1530/EJE-09-0333. Epub 2009 Aug 14.

PMID:
19684051
23.

Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly.

Theodoropoulou M, Tichomirowa MA, Sievers C, Yassouridis A, Arzberger T, Hougrand O, Deprez M, Daly AF, Petrossians P, Pagotto U, Beckers A, Stalla GK.

Int J Cancer. 2009 Nov 1;125(9):2122-6. doi: 10.1002/ijc.24602.

24.

Does the nadir growth-hormone level predict response to somatostatin-analogue therapy?

Beckers A, Daly A, Petrossians P.

Nat Clin Pract Endocrinol Metab. 2006 Jan;2(1):12-3. No abstract available.

PMID:
16932246
25.

Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs.

Petrossians P, Borges-Martins L, Espinoza C, Daly A, Betea D, Valdes-Socin H, Stevenaert A, Chanson P, Beckers A.

Eur J Endocrinol. 2005 Jan;152(1):61-6.

Supplemental Content

Loading ...
Support Center